Toxoplasma chorioretinitis
ICD-10 B58.01 is a billable code used to indicate a diagnosis of toxoplasma chorioretinitis.
Toxoplasma chorioretinitis is an ocular manifestation of Toxoplasma gondii infection, a protozoan parasite that can cause significant morbidity, particularly in immunocompromised individuals and during pregnancy. The condition is characterized by inflammation of the choroid and retina, leading to symptoms such as blurred vision, floaters, and in severe cases, vision loss. Toxoplasmosis is often acquired through ingestion of oocysts from contaminated food or water, or through vertical transmission from mother to fetus. Diagnosis typically involves clinical examination, serological testing for Toxoplasma antibodies, and imaging studies such as optical coherence tomography (OCT) or fundus photography. Treatment usually includes the use of pyrimethamine and sulfadiazine, along with folinic acid to mitigate the side effects of pyrimethamine. Early diagnosis and treatment are crucial to prevent complications and preserve vision.
Detailed documentation of visual acuity, fundoscopic findings, and any imaging results.
Patients presenting with blurred vision, floaters, or acute vision loss.
Ensure that all ocular findings are documented to support the diagnosis of chorioretinitis.
Comprehensive history of exposure, serological test results, and treatment plans.
Immunocompromised patients with systemic symptoms and ocular involvement.
Document the patient's immune status and any relevant comorbidities.
Used for follow-up visits in patients diagnosed with Toxoplasma chorioretinitis.
Document visual acuity, fundoscopic findings, and any changes in symptoms.
Ophthalmologists should ensure thorough documentation of ocular health.
Common symptoms include blurred vision, floaters, and in severe cases, vision loss. Patients may also experience eye pain and redness.
